tirzepatide landmark trial for masld Tirzepatide, the active ingredient behind the popular weight loss drug Zepbound and the diabetes drug Mounjaro, has more tricks up its sleeve. Research out this week shows that it can do wonders At a glance factsheet: Tirzepatide

Results from Eli Lillys SURMOUNT-2 trial are in, and they further confirmed that its GLP-1 agonist tirzepatide (aka Mounjaro) drives meaningful weight loss among obese or overweight adults with type 2 diabetes

Are you struggling with long-term weight management, tired of fad diets, you want the benefits of tirzepatide without the cost associated with brand names like Zepbound

One should start by preparing to inject Zepbound by removing the pen from the refrigerator and inspecting it for damage and expiration

The FDA declared the tirzepatide shortage resolved in October 2024

If your next dose is within four days, skip the missed dose and resume normally

"Sometimes I get a hard lump under the skin that stays for a week